arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

GLOBUS MEDICAL INC

GMED
$73.97 ▼ -1.24 (-1.65%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
62 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Bullish
auto_awesome

Analytical Summary

GLOBUS MEDICAL INC shows strong fundamentals with top-quartile Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $10.0B
Dividend Yield
Revenue Growth 5.9%
Op. Margin 23.1%
ROIC 3.1%
FCF / Share $1.31
Trailing P/E 66.0x
Price / Book 2.1x
FCF Yield 1.8%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

62-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$789.61M
↑ +5.9%
Net Income Profit after all expenses
$151.57M
↓ -25.3%
Operating Margin Operating profit as % of sales
23.1%
↑ +16.7% 69th
FCF / Share Free cash flow per share
$1.31
↑ +8.7%
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
77
Returns
73
Cash Quality
69

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 62 quarters